---
figid: PMC7278913__ijms-21-03534-g003
figtitle: SMAD4 loss and potential therapeutic strategies in SMAD4 signaling
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7278913
filename: ijms-21-03534-g003.jpg
figlink: pmc/articles/PMC7278913/figure/ijms-21-03534-f003/
number: F3
caption: Effects of SMAD4 loss and potential therapeutic strategies in SMAD4 signaling.
  In normal cells, SMAD4 acts as an intracellular mediator of TGFβ. In SMAD4-null
  cells, loss of SMAD4 leads to upregulation of the cell cycle and phosphoglycerate
  kinase 1 (PGK1), leading to tumor promotion. Therapies based on SMAD4 can be direct
  by targeting SMAD4 miRNA regulators to modulate SMAD4 or indirect by targeting a
  downstream component. SMAD4 loss leads to the enhanced efficacy of agents modulating
  the cell cycle, whereby SMAD4 as a biomarker could be useful to stratify therapies.
papertitle: SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma.
reftext: Julie Dardare, et al. Int J Mol Sci. 2020 May;21(10):3534.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.966531
figid_alias: PMC7278913__F3
figtype: Figure
redirect_from: /figures/PMC7278913__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7278913__ijms-21-03534-g003.html
  '@type': Dataset
  description: Effects of SMAD4 loss and potential therapeutic strategies in SMAD4
    signaling. In normal cells, SMAD4 acts as an intracellular mediator of TGFβ. In
    SMAD4-null cells, loss of SMAD4 leads to upregulation of the cell cycle and phosphoglycerate
    kinase 1 (PGK1), leading to tumor promotion. Therapies based on SMAD4 can be direct
    by targeting SMAD4 miRNA regulators to modulate SMAD4 or indirect by targeting
    a downstream component. SMAD4 loss leads to the enhanced efficacy of agents modulating
    the cell cycle, whereby SMAD4 as a biomarker could be useful to stratify therapies.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMAD4
  - TGFB1
  - TGFB2
  - TGFB3
  - TRIOBP
  - TRA
  - THRA
  - TRAC
  - TRI-AAT9-1
  - AMPD1
  - MXD1
  - MIR421
  - MXD4
  - SMAD1
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - PGK1
  - mid
  - Med
  - dpp
  - gbb
  - put
  - mav
  - tara
  - tra
  - byn
  - tri
  - Mad
  - CG2662
  - Mnt
  - ash2
  - CycE
  - cyc
  - Smox
  - Pgk
  - tumor
---
